Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy.

Item

http://www.wikidata.org/entity/Q42591676

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy.

@en

Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy.

@nl

type

Item

label

Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy.

@en

Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy.

@nl

prefLabel

Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy.

@en

Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy.

@nl

P1476

Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy

@en

P2093

Andrew J Porter

http://www.w3.org/2001/XMLSchema#string

Angela Douglass

http://www.w3.org/2001/XMLSchema#string

Caroline Barelle

http://www.w3.org/2001/XMLSchema#string

Karen Wallace

http://www.w3.org/2001/XMLSchema#string

Matthew Koruth

http://www.w3.org/2001/XMLSchema#string

P2860

Synaptophysin, a major synaptic vesicle protein, is not essential for neurotransmitter release

Synaptophysin: A novel marker for human and rat hepatic stellate cells

A ribosomal S-6 kinase-mediated signal to C/EBP-beta is critical for the development of liver fibrosis

Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells

Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis

A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis

TGF-beta signaling in tumor suppression and cancer progression

Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells--a potential mechanism for targeting liver anti-fibrotic therapeutics.

Generation and optimization of human antagonistic antibodies against TIMP-1 as potential therapeutic agents in fibrotic diseases.

The use of phage display peptide libraries for basic and translational research.

P2888

s12072-008-9093-y

P304

405-415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12072-008-9093-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Matthew C. Wright

P577

2008-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26730882

http://www.w3.org/2001/XMLSchema#string

P698

19669316

http://www.w3.org/2001/XMLSchema#string

P932

2716909

http://www.w3.org/2001/XMLSchema#string